Pharmaceutical company Takeda 4502, -0.24% said Wednesday that the U.S. Food and Drug Administration approved Fruzaqla as a treatment for certain patients with colorectal...
In this article I use AAII’s A+ Investor Stock Grades to provide insight into three streaming service stocks. With consumers ditching television providers and...
Quietly, the U.S. government and private credit issuance are edging out public (SEC-regulated) credit markets. The trend began before the pandemic and it is...
The Frankfurt Stock Exchange has listed the creation of a digital asset platform making development areas of its “Horizon 2026” strategy. In a recent...
Synaptics Inc.’s SYNA, -0.16% stock surged 14% in extended trading Thursday after the semiconductor company reported quarterly results that topped analyst revenue and earnings...
By Ben Glickman Shares of Atara Biotherapeutics tumbled on Wednesday after the company said its treatment for non-active progressive multiple sclerosis failed to meet...